CD 123 is a membrane biomarker and a therapeutic target in hematologic malignanciesUgo Testa, Arthur E. Frankel|Biomarker Research|2014Cited by 249
BRAF status and mitogen-activated protein/extracellular signal-regulated kinase kinase 1/2 activity indicate sensitivity of melanoma cells to anthrax lethal toxinRalph J. Abi‐Habib, Arthur E. Frankel|Molecular Cancer Therapeutics|2005Cited by 73
Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanomaUğur Eskiocak, Sean J. Morrison, Jennifer G. Gill et al.|Nature Communications|2016Cited by 69